FDA 483 - Neurolign USA, Llc - October 13, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Neurolign USA, llc in Pittsburgh, PA, revealed three observations related to their manufacturing practices. The firm was cited for not establishing quality control procedures for electronic product radiation safety, failing to submit required annual reports for their products, and not affixing permanent certification labels to their medical devices. These issues indicate deficiencies in regulatory compliance concerning product safety and reporting.
ID · 00cce877-9680-45cd-bc48-b5ec84ee116f